Facebook Twitter YouTube LinkedIn Reddit

Sona Nanotech Inc.

Disclaimer: All stock information on InvestorIntel.com is currently being fed from multiple sources and is updated automatically every 10-minutes. The information on this site is for information purposes only and InvestorIntel Corp. is neither responsible nor liable for the accuracy of this data.

InvestorIntel Features on Sona Nanotech Inc.

David Regan on Sona Nanotech’s rapid-result saliva based COVID-19 test

In a recent InvestorIntel interview, Chris Thompson spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB: SNANF) […]

Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test

Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess one positive […]

Company Overview

Team | Website

Sona Nanotech is a nanotechnology life sciences firm that has developed multiple proprietary methods for the manufacture of various types of gold nanoparticles. The principal business carried out and intended to be continued by Sona is the development and application of its proprietary technologies for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market. Sona Nanotech’s gold nanorod particles are CTAB (cetyltrimethylammonium) free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. It is expected that Sona’s gold nanotechnologies may be adapted for use in applications, as a safe and effective delivery system for multiple medical treatments, subject to the approval of various regulatory boards, including Health Canada and the FDA.

News Releases

Facebook Twitter YouTube LinkedIn Reddit